4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-23-048612
Chief Financial Officer bought 9,490 shares at $7.90 ($74,971)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Balthaser Kevin Chief Financial Officer | 2023-09-06 | Purchase | +9,490 | $7.90 | $74,971 | 15,461 | D |
| Open-market purchases · 9,490 sh · avg $7.90 · $74,971 | |||||||
Loading xslF345X05/doc4.xml…